PMID: 489192Jul 1, 1979Paper

Protective antiallergic effects of a new coumarin compound (BM 15.100) in experimental asthma

International Journal of Clinical Pharmacology and Biopharmacy
E GonsiorB Wüthrich

Abstract

The antiallergic properties of a new coumarin compound (BM 15.100) were tested in two separate trials, using bronchial provocation tests in asymptomatic volunteers with extrinsic allergic bronchial asthma. Study I was a blind study in 10 subjects with placebo controls and three additional non-medicated controls. Study II was an open study with non-medicated controls. Body plethysmography (study I) and spirometry (study II) were used for the assessment of bronchial obstruction. A significant protective effect of a single oral 20 mg dose of BM 15.100 administered 60 min prior to allergen inhalation was found in both trials. The effect of 10 mg BM 15.000 was not significant. Skin test, pulse rate, and diastolic blood pressure were not influenced. The results indicate a possible therapeutical value of BM 15.100.

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.